Please login to the form below

Not currently logged in
Email:
Password:

Jan Reiss moves from PAN Unlimited to IGNIFI

She joins as strategic business development director

IGNIFI Jan ReissUK-based IGNIFI has appointed Jan Reiss as its new strategic development director.

In this newly created role, Reiss will be responsible for driving new business and overseeing the strategic development of existing client partnerships.

Dave Watson, managing director of IGNIFI, said: “Jan's appointment is strategically significant, and will help us fuel growth and development in the pharmaceutical and healthcare sector – a key part of our health, active lifestyle and wellbeing focus.

“Jan's experience and insight enhances our existing skill set and will help bring our capabilities to a wider audience.”

Prior to joining the creative agency, Reiss served as an associate director in business development at PAN Unlimited, now PAN DJM Unlimited.

She also brings 11 years of client service experience in healthcare communications, having worked at CDM London, DDB Remedy, Langland and Medicus International.

Reiss said: “I am thrilled to have joined the team at IGNIFI. … there is an ethos at IGNIFI that we want our clients to truly enjoy working with us, which manifests itself in great client-agency relationship, and makes working here thoroughly enjoyable.”

10th February 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...

Infographics